Quantitative measure of asymptomatic cardiovascular disease risk in Type 2 diabetes: Evidence from Indian outpatient setting.
Asymptomatic
CV risk
Indian patients
QRISK3
Type 2 diabetes
Journal
Indian heart journal
ISSN: 2213-3763
Titre abrégé: Indian Heart J
Pays: India
ID NLM: 0374675
Informations de publication
Date de publication:
Historique:
received:
28
10
2019
revised:
28
02
2020
accepted:
28
03
2020
entrez:
15
6
2020
pubmed:
15
6
2020
medline:
4
3
2021
Statut:
ppublish
Résumé
The cardiovascular (CV) risk of patients with Type 2 diabetes (T2D) of Indo-Asian descent has never been objectively assessed, although it is documented that they have a higher prevalence of CV disease (CVD). To identify groups of Indian patients with asymptomatic T2D who are at high risk of CVD as per the QRISK calculator. After an adequate power calculation, a nation-wide study of patients with asymptomatic T2D was conducted. The QRISK3 scores of these patients were used to derive a 10-year risk of CV events. High CVD risk was defined as ≥20% risk of CV event in 10 years. For a total of 1538 patients across 154 outpatient departments, the QRISK3 scores were collated. Median 10-year CVD risk was 22.2%. Mean 10-year CVD risk was 28.4% (standard deviation 22.1%), representing a 5.7-fold increase vs. controls (i.e., matched healthy adults). Absolute CVD risk increased linearly with age. Over 50% of T2D males aged above 45 years had a high (>20%) CVD risk. Women aged more than 55 years had a high risk of CVD. More than 50% of patients with a T2D duration of more than 5 years had a high risk of CVD as per the QRISK3 calculator.
Sections du résumé
BACKGROUND
BACKGROUND
The cardiovascular (CV) risk of patients with Type 2 diabetes (T2D) of Indo-Asian descent has never been objectively assessed, although it is documented that they have a higher prevalence of CV disease (CVD).
AIMS
OBJECTIVE
To identify groups of Indian patients with asymptomatic T2D who are at high risk of CVD as per the QRISK calculator.
METHOD
METHODS
After an adequate power calculation, a nation-wide study of patients with asymptomatic T2D was conducted. The QRISK3 scores of these patients were used to derive a 10-year risk of CV events. High CVD risk was defined as ≥20% risk of CV event in 10 years.
RESULTS
RESULTS
For a total of 1538 patients across 154 outpatient departments, the QRISK3 scores were collated. Median 10-year CVD risk was 22.2%. Mean 10-year CVD risk was 28.4% (standard deviation 22.1%), representing a 5.7-fold increase vs. controls (i.e., matched healthy adults). Absolute CVD risk increased linearly with age. Over 50% of T2D males aged above 45 years had a high (>20%) CVD risk. Women aged more than 55 years had a high risk of CVD. More than 50% of patients with a T2D duration of more than 5 years had a high risk of CVD as per the QRISK3 calculator.
Identifiants
pubmed: 32534684
pii: S0019-4832(20)30052-3
doi: 10.1016/j.ihj.2020.03.010
pmc: PMC7296234
pii:
doi:
Types de publication
Journal Article
Multicenter Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
119-122Informations de copyright
Copyright © 2020 Cardiological Society of India. Published by Elsevier B.V. All rights reserved.
Déclaration de conflit d'intérêts
Conflicts of interest All authors have none to declare.
Références
Heart. 2012 Mar;98(5):360-9
pubmed: 22184101
Eur Heart J. 2020 Jan 7;41(2):255-323
pubmed: 31497854
Diabetes Metab J. 2018 Oct;42(5):355-363
pubmed: 30362301
Am J Cardiol. 2017 Mar 1;119(5):705-711
pubmed: 28024655
Lancet Glob Health. 2018 Dec;6(12):e1339-e1351
pubmed: 30219317
Diabetol Metab Syndr. 2017 Apr 20;9:25
pubmed: 28435446
Circulation. 2016 Nov 8;134(19):1419-1429
pubmed: 27682883
Cardiovasc Diabetol. 2018 Jun 8;17(1):83
pubmed: 29884191
PLoS Med. 2018 Jun 19;15(6):e1002581
pubmed: 29920517
Diabetes Care. 2019 Jan;42(Suppl 1):S103-S123
pubmed: 30559236
Circulation. 2018 Jul 3;138(1):e1-e34
pubmed: 29794080
Circulation. 2008 Feb 12;117(6):743-53
pubmed: 18212285
N Engl J Med. 2017 Apr 13;376(15):1407-1418
pubmed: 28402770
BMJ Open Diabetes Res Care. 2014 Dec 04;2(1):e000048
pubmed: 25489485
BMJ. 2017 May 23;357:j2099
pubmed: 28536104
Prim Care Diabetes. 2011 Apr;5(1):45-56
pubmed: 20869934
Am J Cardiol. 2014 Jun 1;113(11):1782-7
pubmed: 24746030
Circulation. 2016 Apr 19;133(16):1605-20
pubmed: 27142605